UK markets closed

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6900-0.0098 (-1.40%)
At close: 04:00PM EDT
0.6900 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
25,841
92,942
106,084
200,404
Other short-term investments
25,884
149,877
264,984
300,255
Total cash
51,725
242,819
371,068
500,659
Net receivables
34,108
40,221
986
1,250
Inventory
9,706
1,586
0
-
Other current assets
6,184
10,308
12,373
-
Total current assets
101,869
295,080
384,621
523,273
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
74,660
86,744
108,677
82,496
Accumulated depreciation
-15,869
-12,422
-28,738
-19,676
Net property, plant and equipment
58,791
74,322
79,939
62,820
Other long-term assets
4,844
7,018
3,567
2,027
Total non-current assets
63,635
81,340
83,506
64,847
Total assets
165,504
376,420
468,127
588,120
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,684
6,871
17,368
7,118
Accrued liabilities
37,011
32,746
19,755
19,885
Deferred revenues
77,833
8,000
40,760
33,455
Total current liabilities
142,226
78,916
105,786
82,901
Non-current liabilities
Deferred revenues
37,562
77,000
55,708
27,795
Other long-term liabilities
39,254
35,800
1,501
2,044
Total non-current liabilities
122,509
170,864
82,727
42,880
Total liabilities
264,735
249,780
188,513
125,781
Stockholders' equity
Common stock
11
10
9
8
Retained earnings
-1,969,150
-1,693,024
-1,464,722
-1,124,581
Accumulated other comprehensive income
-204
-2,067
-368
296
Total stockholders' equity
-99,231
126,640
279,614
462,339
Total liabilities and stockholders' equity
165,504
376,420
468,127
588,120